Komori
Susmed (4263) · PolicyRestated

No-Dividend Policy

First written in FY2022-Q2. 13 of 14 entries say "Restated". Latest entry: 2026-09-04.

14entries
5years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022-Q2 – 2026-09-042022: 420222023: 420232024: 220242025: 120252026: 32026
Same theme, other companies
Continuation of a no-dividend policyA theme 52 companies write about · 36 as a headwind · 0 as a tailwind

33 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 52 companies compared. The sentences above are computed from all 52.
Full recordFilings, disclosures and news, newest first
  2. FY2026-H1RestatedAnnual report

    「As we do not pay dividends, no per-share dividend amount is disclosed.」

    The company continues to pay no dividends.
  3. FY2025-H1RestatedAnnual report

    「As we do not pay dividends, no per-share dividend amount is disclosed.」

    The company continues to pay no dividends.
  4. FY2024-Q3RestatedAnnual report

    「As we do not pay dividends, no per-share dividend amount is disclosed.」

    The company continues to pay no dividends.
  5. FY2024-Q2RestatedAnnual report

    「As we do not pay dividends, no per-share dividend amount is disclosed.」

    The company continues to pay no dividends.
  6. FY2024-Q1RestatedAnnual report

    「As we do not pay dividends, no per-share dividend amount is disclosed.」

    The company continues to pay no dividends.
  7. FY2023RestatedAnnual report

    「For the time being, we will prioritize securing funds for the continued and planned implementation of research and development activities involving substantial upfront investment and will not pay dividends.」

    The company continues to prioritize research and development funding and maintain its policy of paying no dividends for the time being.
  8. FY2023-Q3RestatedAnnual report

    「As we do not pay dividends, no per-share dividend amount is disclosed.」

    The company continues to pay no dividends.
  9. FY2023-Q2RestatedAnnual report

    「As we do not pay dividends, no per-share dividend amount is disclosed.」

    The company continues to pay no dividends.
  10. FY2023-Q1RestatedAnnual report

    「As we do not pay dividends, no per-share dividend amount is disclosed.」

    The company continues to pay no dividends.
  11. FY2022RestatedAnnual report

    「For the time being, we will prioritize securing funds for the continued and planned implementation of research and development activities involving substantial upfront investment and will not pay dividends.」

    The company continues to prioritize research and development funding and maintain its policy of paying no dividends for the time being.
  12. FY2022-Q3RestatedAnnual report

    「As we do not pay dividends, no per-share dividend amount is disclosed.」

    The company continues to pay no dividends.
  13. FY2022-Q2First statedAnnual report

    「As we do not pay dividends, no per-share dividend amount is disclosed.」

    The filing states that no dividends were being paid as of the filing date.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Susmed's next results are scheduled for 2026-11-06. Read the earnings preview It last moved in the General Meetings of Shareholders of 2026-09-04: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
No-Dividend Policy | SUSMED,Inc. (4263) | Komori